Anna Oleksiak, MD PhD (@ann_oleksiak) 's Twitter Profile
Anna Oleksiak, MD PhD

@ann_oleksiak

clinician at ICCU in @nikardiologii & researcher / #ACVC_ESC YNA / #EHJACVC Team/ lipidologist & EAS fellow / acute cardiac care, CT & graphic design passionate

ID: 1599870025871097856

calendar_today05-12-2022 20:55:24

70 Tweet

61 Followers

80 Following

ACVCPresident (@acvcpresident) 's Twitter Profile Photo

Are you ready to 🎢 into #AcuteCVDays? Be challenged and get the ✅ answer 🆓 escardio.org/Sub-specialty-… Antiplatelets and OAC combo in #ACS pts w AF and CHA2DS2-VASc ≥1 in ♂️ and ≥2 in ♀️ which treatment duration is recommended as default strategy following the ACS? Pool👇

Are you ready to 🎢 into #AcuteCVDays? 
Be challenged and get the ✅ answer
🆓 escardio.org/Sub-specialty-…

Antiplatelets and OAC combo in #ACS pts w AF and CHA2DS2-VASc  ≥1 in ♂️ and ≥2 in ♀️ which treatment duration is recommended as default strategy following the ACS?

Pool👇
EHJACVC Editor-in-Chief (@ehjacvceic) 's Twitter Profile Photo

Early #MCS in #CardShock - is the timing crucial ? Can we get the answer in editorial by Kiran Sidhu and Y.Kwon? 👇 #EHJACVC doi.org/10.1093/ehjacc… Or 🏃 to the original 📝 by Buda et al. doi.org/10.1093/ehjacc… What can you find there?👇 Video highlights by Maria Bergami, MD, PhD

European Society of Cardiology Journals (@esc_journals) 's Twitter Profile Photo

Are there differences in #SCAD outcomes according to pregnancy status ? From NRD database: - 20922 women with SCAD, 2.8% 🤰 - P-SCAD vs. NP-SCAD: ⬇️ mortality ⬆️ 30d readmission bit.ly/4aKoR3b EHJACVC Editor-in-Chief Milica Aleksic ACVCPresident Maria Bergami, MD, PhD Anna Oleksiak, MD PhD

Are there differences in #SCAD outcomes according to pregnancy status ?

From NRD database:

- 20922 women with SCAD, 2.8% 🤰 

- P-SCAD vs. NP-SCAD:

⬇️ mortality

⬆️ 30d readmission
bit.ly/4aKoR3b <a href="/EHJACVCEiC/">EHJACVC Editor-in-Chief</a> <a href="/drmilicaa/">Milica Aleksic</a> <a href="/ACVCPresident/">ACVCPresident</a> <a href="/maria_bergami/">Maria Bergami, MD, PhD</a> <a href="/ann_oleksiak/">Anna Oleksiak, MD PhD</a>
Anna Oleksiak, MD PhD (@ann_oleksiak) 's Twitter Profile Photo

How much do we know about antithrombotic management during #pMCS ? Check my new video highlights & read an excellent experts commentary regarding original research by Christophe Vandenbriele and colleagues published recently in #EHJACVC ... ...& let's follow EHJACVC Editor-in-Chief for more science!

EHJACVC Editor-in-Chief (@ehjacvceic) 's Twitter Profile Photo

Welcome to the MAY edition of #EHJACVC If you like the editorial 👇 doi.org/10.1093/ehjacc… dive deep into original papers 👇 ➡️ doi.org/10.1093/ehjacc… ➡️ doi.org/10.1093/ehjacc… ➡️doi.org/10.1093/ehjacc… ➡️doi.org/10.1093/ehjacc… Video highlights by Anna Oleksiak, MD PhD

EHJACVC Editor-in-Chief (@ehjacvceic) 's Twitter Profile Photo

MAY edition in continuum 🔥 #EHJACVC Waldauf et al. -propafenone vs amiodarone for SVT in septic shock 👇 doi.org/10.1093/ehjacc… Davide Capodanno et al. shed the 💡into periprocedural #AMI - is there time for an update in 5th universal #AMI definition ? 👇 doi.org/10.1093/ehjacc…

European Society of Cardiology Journals (@esc_journals) 's Twitter Profile Photo

Are we doing enough for post-MI patients? Results by GULLIVE-R study (2509 🙎‍♂️) are worrisome: • 37.9% 🙎‍♂️ knew about SBP📈, 8.2 % LDL-C 📈 • 🙎‍♂️ and 👩‍🔬 underestimated future MI risk bit.ly/4bAmmAV EHJACVC Editor-in-Chief Milica Aleksic ACVCPresident Maria Bergami, MD, PhD Anna Oleksiak, MD PhD

Are we doing enough for post-MI patients?
Results by GULLIVE-R study (2509 🙎‍♂️) are worrisome:
•  37.9% 🙎‍♂️ knew about SBP📈, 8.2 %  LDL-C 📈
•  🙎‍♂️ and 👩‍🔬 underestimated future MI risk
bit.ly/4bAmmAV

<a href="/EHJACVCEiC/">EHJACVC Editor-in-Chief</a> <a href="/drmilicaa/">Milica Aleksic</a> <a href="/ACVCPresident/">ACVCPresident</a> <a href="/maria_bergami/">Maria Bergami, MD, PhD</a> <a href="/ann_oleksiak/">Anna Oleksiak, MD PhD</a>
EHJACVC Editor-in-Chief (@ehjacvceic) 's Twitter Profile Photo

Welcome to the JUNE edition of #EHJACVC - new frontiers in #cvacute doi.org/10.1093/ehjacc…   #DanGerShock #FLAME  #ECLSSHOCK Enjoy the editorial and subscribe to our bulletin for more groundbreaking science   Video highlights by Anna Oleksiak, MD PhD European Society of Cardiology Journals

Anna Oleksiak, MD PhD (@ann_oleksiak) 's Twitter Profile Photo

Ogromne podziękowania dla Narodowy Instytut Kardiologii za kolejną, już trzecią w czasie mojej rezydentury, nagrodę dla Młodego Badacza, i przede wszystkim za stworzenie możliwości do rozwoju naukowego! facebook.com/share/p/dsY1pF…

Ogromne podziękowania dla <a href="/nikardiologii/">Narodowy Instytut Kardiologii</a> za kolejną, już trzecią w czasie mojej rezydentury, nagrodę dla Młodego Badacza, i przede wszystkim za stworzenie możliwości do rozwoju naukowego! facebook.com/share/p/dsY1pF…
Anna Oleksiak, MD PhD (@ann_oleksiak) 's Twitter Profile Photo

I am very honored to be part of European Atherosclerosis Society Young Fellows programme class 2025-2026 as the second Polish woman (the first was very talented doctor Joanna Lewek in 2019-2021 class) in the history of this educational & mentorship programme eas-society.org/education/eas-…

European Society of Cardiology Journals (@esc_journals) 's Twitter Profile Photo

Among #STEMI pts undergoing #PCI, the use of prehospital tirofiban was independently associated w/ ⬆ rate of disrupted #MI (8% vs 4%) & ⬇ mortality at 1y FUP (0 vs 2.6%) Check this out in #EHJACVC ➡ bit.ly/4c1CSde EHJACVC Editor-in-Chief ACVCPresident Milica Aleksic Anna Oleksiak, MD PhD

Among #STEMI pts undergoing #PCI, the use of prehospital tirofiban was independently associated w/ ⬆ rate of disrupted #MI (8% vs 4%) &amp; ⬇ mortality at 1y FUP (0 vs 2.6%) 
Check this out in #EHJACVC ➡ bit.ly/4c1CSde

<a href="/EHJACVCEiC/">EHJACVC Editor-in-Chief</a> <a href="/ACVCPresident/">ACVCPresident</a> <a href="/drmilicaa/">Milica Aleksic</a> <a href="/ann_oleksiak/">Anna Oleksiak, MD PhD</a>
European Society of Cardiology Journals (@esc_journals) 's Twitter Profile Photo

Is there any place for transfemoral #PCI? Significant differences exist between transfemoral & transradial access #PCI in #AMICS incl. higher 30-day mortality in patients with transfemoral procedure -> bit.ly/3xuJQss EHJACVC Editor-in-Chief ACVCPresident Milica Aleksic Anna Oleksiak, MD PhD

Is there any place for transfemoral #PCI? Significant differences exist between transfemoral &amp; transradial access #PCI in #AMICS incl. higher 30-day mortality in patients with transfemoral procedure -&gt; bit.ly/3xuJQss

<a href="/EHJACVCEiC/">EHJACVC Editor-in-Chief</a> <a href="/ACVCPresident/">ACVCPresident</a> <a href="/drmilicaa/">Milica Aleksic</a> <a href="/ann_oleksiak/">Anna Oleksiak, MD PhD</a>
EHJACVC Editor-in-Chief (@ehjacvceic) 's Twitter Profile Photo

Welcome to the July Edition of #EHJACVC where you can explore new groundbreaking science If you want to have a closer look into the papers follow the below links👇📖 Hong et al. doi.org/10.1093/ehjacc… Zeymer et al.  doi.org/10.1093/ehjacc… Eggers et al.

EHJACVC Editor-in-Chief (@ehjacvceic) 's Twitter Profile Photo

Pre-hospital antiplatelets in #STEMI How to use? What's new?  We are looking for answers in a new educational paper  doi.org/10.1093/ehjacc… There are still many questions unanswered 🤔 ✍️When? ✍️Who? ✍️How? Until some larger #RCTs we rely on our clinical judgement #EHJACVC